Lena Wijk

About

Lena Wijk is a leading clinical researcher in gynecologic surgery, with a primary focus on optimizing surgical outcomes for women undergoing hysterectomy and cancer treatment. Her most impactful work centers on two key areas: the comparative effectiveness of robotic-assisted versus abdominal surgery, and the implementation of Enhanced Recovery After Surgery (ERAS) protocols. Wijk’s landmark contribution is the RACC trial (2019, 150 citations), a pivotal international multi-center randomized controlled trial that rigorously evaluated the robot-assisted approach to cervical cancer, providing high-level evidence on safety and efficacy. She has also advanced the understanding of perioperative physiology, investigating metabolic and inflammatory responses to different surgical techniques, as well as the role of female sex hormones in post-surgical insulin resistance. Through her observational study on Enhanced Recovery After Hysterectomy, Wijk has helped shape modern perioperative care, demonstrating how standardized ERAS pathways can improve recovery times and patient outcomes. Her work bridges the gap between surgical innovation and patient-centered recovery, making her a key voice in the movement toward minimally invasive, evidence-based gynecologic surgery.

Research Focus

Key Achievements

Top Papers

1. 1
   Robot-assisted approach to cervical cancer (RACC): an international multi-center, open-label randomized controlled trial

   150 citations · 2019
2. 2
   Metabolic and inflammatory responses and subsequent recovery in robotic versus abdominal hysterectomy: A randomised controlled study

   21 citations · 2016
3. 3
   Enhanced Recovery After Hysterectomy

   3 citations · 2017
4. 4
   Female sex hormones in relation to insulin resistance after hysterectomy: A pilot study

   3 citations · 2018

Key Collaborators

Contact & Links